Press Releases

Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company, has announced that the company is going to commence research for developing a vaccine for Corona Virus (COVID-19), the pandemic which has infected more than a million and killed about...

Thermo Fisher Scientific Inc., the world leader in serving science, is accelerating its efforts with diagnostic testing and vaccine development technologies to effectively manage COVID-19 outbreak in the country. In India, Thermo Fisher is working closely with the relevant government...

Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic. The companies will combine expertise to discover and develop fully human neutralizing antibodies targeting SARS-CoV-2 to potentially prevent or treat COVID-19. The mutually exclusive collaboration...

APEIRON Biologics AG announced that it has received regulatory approvals in Austria, Germany and Denmark to initiate a Phase II clinical trial of APN01 to treat COVID-19. APN01 is the recombinant form of the human angiotensin-converting enzyme 2 (rhACE2),...

The Medicines Discovery Catapult will open a new dedicated laboratory at Bruntwood SciTech’s Alderley Park in Cheshire, making it one of the government’s national hubs for Covid-19 testing. Medicines Discovery Catapult is also helping to co-ordinate the establishment of the...

Sense has announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. Sense is partnering closely with Phillips-Medisize, a Molex company and leading global medical device innovator,...

The agency granted an emergency use authorization to the company for its test, which is meant to detect antibodies against SARS-CoV-2 in the blood. However, antibody testing has both advantages and disadvantages relative to the more common PCR assays. The...